Cerevel Therapeutics Holdings Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Cerevel Therapeutics prevailing Real Value cannot be determined due to lack of data. The current price of Cerevel Therapeutics is $0.0. Our model approximates the value of Cerevel Therapeutics from analyzing the firm fundamentals such as Return On Equity of -0.92, shares owned by insiders of 15.32 %, and Current Valuation of 7.71 B as well as examining its technical indicators and probability of bankruptcy.
Cerevel Therapeutics Total Value Analysis
Cerevel Therapeutics Holdings is currently projected to have valuation of 7.71 B with market capitalization of 8.19 B, debt of 480.78 M, and cash on hands of 531.21 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cerevel Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.71 B | 8.19 B | 480.78 M | 531.21 M |
Cerevel Therapeutics Asset Utilization
One of the ways to look at asset utilization of Cerevel is to check how much profit was generated for every dollar of assets it reports. Cerevel Therapeutics Holdings shows a negative utilization of assets of -0.3 percent, losing $0.002979 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cerevel Therapeutics Holdings shows how discouraging it operates for each dollar spent on its assets.Cerevel Therapeutics Ownership Allocation
Cerevel Therapeutics holds a total of 182.2 Million outstanding shares. The majority of Cerevel Therapeutics Holdings outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cerevel Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cerevel Therapeutics. Please pay attention to any change in the institutional holdings of Cerevel Therapeutics Holdings as this could imply that something significant has changed or is about to change at the company. Also note that nearly eight hundred one thousand six hundred fifty-eight invesors are currently shorting Cerevel Therapeutics expressing very little confidence in its future performance.Cerevel Therapeutics Profitability Analysis
Net Loss for the year was (432.84 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cerevel Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cerevel Therapeutics and how it compares across the competition.
Cerevel Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cerevel Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 162.1 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Cerevel Stock
If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |